Stefan Grond
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Stefan Grond has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Lukas Radbruch
Department of Anaesthesiology, University of Cologne, Germany
8 shared publications K A Lehmann
6 shared publications- Rainer Sabatowski
UniversitätsSchmerzCentrum, Universitätsklinik „Carl Gustav Carus“, Dresden, Deutschland
5 shared publications - T. Meuser
Marien-Krankenhaus gGmbH, Bergisch-Gladbach
4 shared publications C. Pietruck
Townsville Hospital of James Cook University/Australien
3 shared publicationsD Zech
3 shared publications
Latest Publications
- Open Access
- 1 June 2007
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 98 (6) , 806-815
Iontophoretic transdermal system using fentanyl compared with patient-controlled intravenous analgesia using morphine for postoperative pain management †
The fentanyl iontophoretic transdermal system (fentanyl ITS) enables needle-free, patient-controlled analgesia for postoperative pain management. This study compared the efficacy, safety, and ease of care of fentanyl ITS with patient-controlled, i.v. analgesia (PCIA) with morphine for postoperative pain management. A prospective, randomized, multicentre trial enrolled patients in Europe after abdominal or orthopaedic surgery. Patients received fentanyl ITS (n = 325; 40.0 µg fentanyl over 10 min) or morphine PCIA [n = 335; bolus doses (standard at each hospital)] for ≤72 h. Supplemental i.v. morphine was available during the first 3 h. The primary efficacy measure was the patient global assessment (PGA) of the pain control method during the first 24 h. PGA ratings of ‘good’ or ‘excellent’ were reported by 86.2 and 87.5% of patients using fentanyl ITS or morphine PCIA, respectively (95% CI, −6.5 to 3.9%). Mean (sd) last pain intensity scores (numerical rating scale, 0–10) were 1.8 (1.77) and 1.9 (1.86) in the fentanyl ITS and morphine PCIA groups, respectively (95% CI, −0.38 to 0.18). More patients reported a system-related problem for fentanyl ITS than morphine PCIA (51.1 vs 17.9%, respectively). However, fewer of these problems interrupted pain control (4.4 vs 41.3%, respectively). Patients, nurses, and physiotherapists reported more favourable overall ease-of-care ratings for fentanyl ITS than morphine PCIA. Study termination rates and opioid-related side-effects were similar between groups. Fentanyl ITS and morphine PCIA were comparably effective and safe.
- 1 June 2007
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 98 (6) , 806-815
Open AccessIontophoretic transdermal system using fentanyl compared with patient-controlled intravenous analgesia using morphine for postoperative pain management †
The fentanyl iontophoretic transdermal system (fentanyl ITS) enables needle-free, patient-controlled analgesia for postoperative pain management. This study compared the efficacy, safety, and ease of care of fentanyl ITS with patient-controlled, i.v. analgesia (PCIA) with morphine for postoperative pain management. A prospective, randomized, multicentre trial enrolled patients in Europe after abdominal or orthopaedic surgery. Patients received fentanyl ITS (n = 325; 40.0 µg fentanyl over 10 min) or morphine PCIA [n = 335; bolus doses (standard at each hospital)] for ≤72 h. Supplemental i.v. morphine was available during the first 3 h. The primary efficacy measure was the patient global assessment (PGA) of the pain control method during the first 24 h. PGA ratings of ‘good’ or ‘excellent’ were reported by 86.2 and 87.5% of patients using fentanyl ITS or morphine PCIA, respectively (95% CI, −6.5 to 3.9%). Mean (sd) last pain intensity scores (numerical rating scale, 0–10) were 1.8 (1.77) and 1.9 (1.86) in the fentanyl ITS and morphine PCIA groups, respectively (95% CI, −0.38 to 0.18). More patients reported a system-related problem for fentanyl ITS than morphine PCIA (51.1 vs 17.9%, respectively). However, fewer of these problems interrupted pain control (4.4 vs 41.3%, respectively). Patients, nurses, and physiotherapists reported more favourable overall ease-of-care ratings for fentanyl ITS than morphine PCIA. Study termination rates and opioid-related side-effects were similar between groups. Fentanyl ITS and morphine PCIA were comparably effective and safe.
- 1 November 2006
- Published by Springer Nature in Der Schmerz
- Vol. 20 (6) , 509-518
Expression und Funktion des ORL-1-Rezeptors auf humanen Leukozyten
Der ORL-1-Rezeptor wird von humanen Leukozyten exprimiert. Über die Funktionsweise dieser Interaktion zwischen Nerven- und Immunsystem ist bisher noch wenig bekannt. Ziel unserer Arbeit war es, die Expression des ORL-1-Rezeptors auf verschiedenen Leukozytensubpopulationen und den Einfluss des Nociceptin-ORL-1-Rezeptor-Systems auf die intrazelluläre Zytokinproduktion zu untersuchen.
- 1 November 2006
- Published by Springer Nature in Der Schmerz
- Vol. 20 (6) , 509-518
Expression und Funktion des ORL-1-Rezeptors auf humanen Leukozyten
Der ORL-1-Rezeptor wird von humanen Leukozyten exprimiert. Über die Funktionsweise dieser Interaktion zwischen Nerven- und Immunsystem ist bisher noch wenig bekannt. Ziel unserer Arbeit war es, die Expression des ORL-1-Rezeptors auf verschiedenen Leukozytensubpopulationen und den Einfluss des Nociceptin-ORL-1-Rezeptor-Systems auf die intrazelluläre Zytokinproduktion zu untersuchen.
- 1 July 2006
- Published by Dustri-Verlag Dr. Karl Feistle in Intensiv- und Notfallbehandlung
- Vol. 31 (7) , 136-141
Evidenzbasierte Intensivmedizin: Welche Leitlinien sollten eingesetzt werden?
- 1 July 2006
- Published by Dustri-Verlag Dr. Karl Feistle in Intensiv- und Notfallbehandlung
- Vol. 31 (7) , 136-141
Evidenzbasierte Intensivmedizin: Welche Leitlinien sollten eingesetzt werden?
- Open Access
- 9 August 2005
- Published by Springer Nature in Critical Care
- Vol. 9 (5) , R530-40
Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients – a randomized clinical trial [ISRCTN62699180]
Introduction: This prospective randomized clinical study investigated the efficacy and safety of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 (7.2% NaCl/HES 200/0.5) in comparison with 15% mannitol in the treatment of increased intracranial pressure (ICP). Methods: Forty neurosurgical patients at risk of increased ICP were randomized to receive either 7.2% NaCl/HES 200/0.5 or 15% mannitol at a defined infusion rate, which was stopped when ICP was < 15 mmHg. Results: Of the 40 patients, 17 patients received 7.2% NaCl/HES 200/0.5 and 15 received mannitol 15%. In eight patients, ICP did not exceed 20 mmHg so treatment was not necessary. Both drugs decreased ICP below 15 mmHg (p < 0.0001); 7.2% NaCl/HES 200/0.5 within 6.0 (1.2–15.0) min (all results are presented as median (minimum-maximum range)) and mannitol within 8.7 (4.2–19.9) min (p < 0.0002). 7.2% NaCl/HES 200/0.5 caused a greater decrease in ICP than mannitol (57% vs 48%; p < 0.01). The cerebral perfusion pressure was increased from 60 (39–78) mmHg to 72 (54–85) mmHg by infusion with 7.2% NaCl/HES 200/0.5 (p < 0.0001) and from 61 (47–71) mmHg to 70 (50–79) mmHg with mannitol (p < 0.0001). The mean arterial pressure was increased by 3.7% during the infusion of 7.2% NaCl/HES 200/0.5 but was not altered by mannitol. There were no clinically relevant effects on electrolyte concentrations and osmolarity in the blood. The mean effective dose to achieve an ICP below 15 mmHg was 1.4 (0.3–3.1) ml/kg for 7.2% NaCl/HES 200/0.5 and 1.8 (0.45–6.5) ml/kg for mannitol (p < 0.05). Conclusion: 7.2% NaCl/HES 200/0.5 is more effective than mannitol 15% in the treatment of increased ICP. A dose of 1.4 ml/kg of 7.2% NaCl/HES 200/0.5 can be recommended as effective and safe. The advantage of 7.2% NaCl/HES 200/0.5 might be explained by local osmotic effects, because there were no clinically relevant differences in hemodynamic clinical chemistry parameters.
- 9 August 2005
- Published by Springer Nature in Critical Care
- Vol. 9 (5) , R530-40
Open AccessEfficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients – a randomized clinical trial [ISRCTN62699180]
Introduction: This prospective randomized clinical study investigated the efficacy and safety of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 (7.2% NaCl/HES 200/0.5) in comparison with 15% mannitol in the treatment of increased intracranial pressure (ICP). Methods: Forty neurosurgical patients at risk of increased ICP were randomized to receive either 7.2% NaCl/HES 200/0.5 or 15% mannitol at a defined infusion rate, which was stopped when ICP was < 15 mmHg. Results: Of the 40 patients, 17 patients received 7.2% NaCl/HES 200/0.5 and 15 received mannitol 15%. In eight patients, ICP did not exceed 20 mmHg so treatment was not necessary. Both drugs decreased ICP below 15 mmHg (p < 0.0001); 7.2% NaCl/HES 200/0.5 within 6.0 (1.2–15.0) min (all results are presented as median (minimum-maximum range)) and mannitol within 8.7 (4.2–19.9) min (p < 0.0002). 7.2% NaCl/HES 200/0.5 caused a greater decrease in ICP than mannitol (57% vs 48%; p < 0.01). The cerebral perfusion pressure was increased from 60 (39–78) mmHg to 72 (54–85) mmHg by infusion with 7.2% NaCl/HES 200/0.5 (p < 0.0001) and from 61 (47–71) mmHg to 70 (50–79) mmHg with mannitol (p < 0.0001). The mean arterial pressure was increased by 3.7% during the infusion of 7.2% NaCl/HES 200/0.5 but was not altered by mannitol. There were no clinically relevant effects on electrolyte concentrations and osmolarity in the blood. The mean effective dose to achieve an ICP below 15 mmHg was 1.4 (0.3–3.1) ml/kg for 7.2% NaCl/HES 200/0.5 and 1.8 (0.45–6.5) ml/kg for mannitol (p < 0.05). Conclusion: 7.2% NaCl/HES 200/0.5 is more effective than mannitol 15% in the treatment of increased ICP. A dose of 1.4 ml/kg of 7.2% NaCl/HES 200/0.5 can be recommended as effective and safe. The advantage of 7.2% NaCl/HES 200/0.5 might be explained by local osmotic effects, because there were no clinically relevant differences in hemodynamic clinical chemistry parameters.
- 1 July 2004
- Published by Springer Nature in Der Anaesthesist
- Vol. 53 (7) , 621-628
Regulation der spinalen Expression von Nociceptin unter neuropathischen Schmerzen
- 1 July 2004
- Published by Springer Nature in Der Anaesthesist
- Vol. 53 (7) , 621-628
Regulation der spinalen Expression von Nociceptin unter neuropathischen Schmerzen
- Top Cited Papers
- 1 January 2004
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 43 (13) , 879-923
Clinical Pharmacology of Tramadol
Tramadol, a centrally acting analgesic structurally related to codeine and morphine, consists of two enantiomers, both of which contribute to analgesic activity via different mechanisms. (+)-Tramadol...
- 1 January 2004
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 43 (13) , 879-923
Top Cited PapersClinical Pharmacology of Tramadol
Tramadol, a centrally acting analgesic structurally related to codeine and morphine, consists of two enantiomers, both of which contribute to analgesic activity via different mechanisms. (+)-Tramadol...
- 21 February 2003
- Vol. 8 (2) , 71-6
Different expression of cytokines in survivors and non-survivors from MODS following cardiovascular surgery.
Cardiopulmonary bypass is often associated with pathophysiological changes in form of systemic inflammatory response syndrome (SIRS) or multiple organ dysfunction syndrome (MODS). In the present study, we investigated plasma levels of pro- and anti-inflammatory cytokines in survivors and non-survivors from MODS in the early postoperative course following open heart surgery. Prospective clinical study. A University Cardiothoracic Intensive Care Unit. Levels of cytokines (IL-6, IL-8, IL-10, IL-18, and TGF- ) and procalcitonin (PCT) were measured at the first four postoperative days in 16 adult male patients with an Apache II-score >24 and two or more organ dysfunctions after myocardial revascularization. All pro-inflammatory cytokines, except for IL-6, were significantly elevated in non-survivors from MODS, with peak values at the first two postoperative days. The plasma levels of immunoinhibitory cytokines showed no differences between the groups. The results of our study show a different expression of pro-inflammatory cytokines in survivors and non-survivors from MODS following operations with extracorporeal circulation. In addition to Apache-II score, especially IL-8, IL-18, and PCT may be used as parameters for the prognosis of patients with organ dysfunctions after cardiac surgery.
- 21 February 2003
- Vol. 8 (2) , 71-6
Different expression of cytokines in survivors and non-survivors from MODS following cardiovascular surgery.
Cardiopulmonary bypass is often associated with pathophysiological changes in form of systemic inflammatory response syndrome (SIRS) or multiple organ dysfunction syndrome (MODS). In the present study, we investigated plasma levels of pro- and anti-inflammatory cytokines in survivors and non-survivors from MODS in the early postoperative course following open heart surgery. Prospective clinical study. A University Cardiothoracic Intensive Care Unit. Levels of cytokines (IL-6, IL-8, IL-10, IL-18, and TGF- ) and procalcitonin (PCT) were measured at the first four postoperative days in 16 adult male patients with an Apache II-score >24 and two or more organ dysfunctions after myocardial revascularization. All pro-inflammatory cytokines, except for IL-6, were significantly elevated in non-survivors from MODS, with peak values at the first two postoperative days. The plasma levels of immunoinhibitory cytokines showed no differences between the groups. The results of our study show a different expression of pro-inflammatory cytokines in survivors and non-survivors from MODS following operations with extracorporeal circulation. In addition to Apache-II score, especially IL-8, IL-18, and PCT may be used as parameters for the prognosis of patients with organ dysfunctions after cardiac surgery.
- 1 December 2002
- Published by Springer Nature in Der Anaesthesist
- Vol. 51 (12) , 996-1005
Nociceptin und der ORL1-Rezeptor
- 1 December 2002
- Published by Springer Nature in Der Anaesthesist
- Vol. 51 (12) , 996-1005
Nociceptin und der ORL1-Rezeptor
- 1 June 2001
- Published by Portico in Pain Reviews
- Vol. 8 (2) , 103-111
Safety and tolerability of opioid analgesia: a comparable class profile?
- 1 June 2001
- Published by Portico in Pain Reviews
- Vol. 8 (2) , 103-111
Safety and tolerability of opioid analgesia: a comparable class profile?
- 1 January 2001
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 18 (Supplement)
Regulation of mu-opioid receptor mRNA in the peripheral nervous system of morphine-tolerant rats
- 1 January 2001
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 18 (Supplement)
Regulation of mu-opioid receptor mRNA in the peripheral nervous system of morphine-tolerant rats